HEMASHIELD PLATINUM WOVEN DOUBLE VELOUR M00202175928P0

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-08-22 for HEMASHIELD PLATINUM WOVEN DOUBLE VELOUR M00202175928P0 manufactured by Intervascular Sas.

Event Text Entries

[117892025] Device is not accessible for testing as it remained implanted in patient. A review of the complaint device history records, indicated that the graft was processed and inspected according to established procedures and was therefore released following acceptable quality inspections and tests. These tests include a 100 % visual inspection of the graft using fluorescent light to reveal the presence of any holes in the textile structure. Moreover, the review of the water permeability testing records of products coated on the same day as the complaint device indicated values well within product specifications. The review of post-marketing historical data indicated that no other similar complaint was reported for the same lot number. A video of the surgery was provided by the user. The corporate medical officer carefully observed this video and commented that "the patient appears to be still on extracorporeal circulation therefore fully heparinized. At this stage of the operation any leakage will be more evident because of the level of heparinization. Moreover, this kind of procedures requires relatively long extracorporeal circulation adoption therefore the coagulation parameters will be more adversely impacted. The leakages appear to be minimal in clinical significance and likely to stop after the administration of protamine. The graft remained implanted and to our knowledge the patient did not have any adverse clinical consequence due to this event. " the investigation is still ongoing. A non-conformity report has been initiated in order to investigate the root cause and take appropriate corrective actions if necessary.
Patient Sequence No: 1, Text Type: N, H10


[117892026] During surgery for aneurysmal disease, the graft has a serious hole bleeding problem. There was no transfusion during the surgery. Surgeon used drugs as novoseven and bioglue to stop the bleeding. The patient remained implanted and stable.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1640201-2018-00019
MDR Report Key7805508
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-08-22
Date of Report2018-10-02
Date of Event2018-07-19
Date Mfgr Received2018-09-10
Device Manufacturer Date2018-04-11
Date Added to Maude2018-08-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. LAURE FRAYSSE
Manufacturer StreetZ.I. ATHELIA I
Manufacturer CityLA CIOTAT CEDEX, 13705
Manufacturer CountryFR
Manufacturer Postal13705
Manufacturer G1INTERVASCULAR SAS
Manufacturer StreetZ.I. ATHELIA I
Manufacturer CityLA CIOTAT CEDEX, 13705
Manufacturer CountryFR
Manufacturer Postal Code13705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMASHIELD PLATINUM WOVEN DOUBLE VELOUR
Generic NameVASCULAR POLYESTER GRAFT
Product CodeMAL
Date Received2018-08-22
Model NumberM00202175928P0
Catalog NumberM00202175928P0
Lot Number18D11
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINTERVASCULAR SAS
Manufacturer AddressZ.I. ATHELIA I LA CIOTAT CEDEX, 13705 FR 13705


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-08-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.